Martin Immanuel Bittner

Chief Executive Officer, Arctoris

Martin-Immanuel Bittner MD DPhil FRSA is the Chief Executive Officer of Arctoris, the drug discovery platform company that he co-founded in Oxford in 2016. Martin graduated as a medical doctor from the University of Freiburg in Germany, followed by his DPhil in Oncology as a Rhodes scholar at the University of Oxford. He has extensive research experience covering both clinical trials and preclinical drug discovery and is an active member of several leading cancer research organisations, including EACR, AACR, and ESTRO. In recognition of his research achievements, he was elected a member of the Young Academy of the German National Academy of Sciences and of Sigma Xi.